Bibliography
Introduction
Abrams,
P., editorial, “LUTS, BPH, BPE,BPO: A Plea for the Logical
Use of Correct Terms,” Reviews in Urology, Spring, 65,
1999.
Fryman,
R.J., Abrams, P., Campbell’s Urology Update, vol. 1,
no. 4, 2000.
Bladder
Outlet Obstruction
5th
International Consultation on BPH, Paris, France, 2000.
McConnell,
J., Bueschen, A., Bruskewitz, R., (faculty) “Urological
Topic Showcases BPH - Current Diagnosis and Treatment Recommendations,”
AUA annual meeting, San Antonio, TX, May, 1993.
Lepor
H., Williford, W.O., Barry, M.J., Brawer, M.K., et al., “The
Efficacy of Terazosin, Finasteride, or Both in Benign Prostatic
Hyperplasia,” NEJM, 335(8): 533-9, 1996.
McConnell,
J.D., Bruskewitz R., Walsh, P., et al., PLESS Study Group:
“The Effect of Finasteride on the Risk of Acute Urinary
Retention and the Need for Surgical Treatment Among Men with
Benign Prostatic Hyperplasia,” NEJM, 338:9, 557-563,
1998.
McConnell,
J.D., Barry, M.J., Bruskewitz, R.,C., et al., “Benign
Prostatic Hyperplasia: Diagnosis and Treatment, Clinical Practice
Guideline No. 8,” U.S. Department of Health and Human
Services, Public Health Agency for Health Care Policy and
Research, AHCPR Publication No. 94-0582, Rockville, MD, Feb.,
1994.
McConnell,
J.D., “Current Medical Therapy for Benign Prostatic
Hyperplasia: The Scientific Basis and Clinical Efficacy of
Finasteride and Alpha-Blockers,” Campbell’s Urology
Update, sixth ed., no. 3, 1-12, 1992.
Barry
MJ., Fowler, Jr., F.J., O’Leary, M.P., et al, “The
American Urological Symptom Index for Benign Prostatic Hyperplasia,”
J Urol, 148: 1549-1557, 1992.
Lloyd,
LK, “The Rationale for Alpha Blockade in the Treatment
of BPH,” Urology Advisory Council Syllabus, Abbot Park,
ILL, 1993.
Siroky,
M.B., Olsson, C.A., Krane, R.J., “The Flow Rate Nomogram.
II. Clinical Correlation,” J Urol, 123:208-210, 1980.
NIH
news release, “Antihypertensive and Lipid Lowering Treatment
to Prevent Heart Attack Trial (ALLHAT), March 8, 2000.
Prostatitis
Meares,
E.M., and Stanley, T.A., “Bacteriologic Localization
Patterns In Bacterial Prostatitis, Investigative Urology,
5:492, 1968.
Meares,
E.M., “Prostatitis and Related Disorders,” Campbell’s
Urology,
sixth ed., 807-822.
Nickel,
J.C., “Prostatitis: Evolving Management Strategies,
The Urologic Clinics N.A.,” Infections In Urology, vol.
26, no. 4, 1999.
Executive
Summary, Chronic Prostatitis Workshop, National Institutes
of Diabetes and Digestive and Kidney Diseases, NIH, Rockville,
MD, Dec. 7-8, 1995.
Krieger,
J.N., Nyberg, L., Nickel, J.C., “NIH Consensus Definition
and Classification of Prostatitis,” JAMA, 282:236-237,
1999.
Overactive
Bladder
P.
Abrams, et al., “The Standardization of Terminology
of Lower Urinary Tract Function: Report from the Standardization
Subcommittee of the International Continence Society,”
Neurourology and Urodynamics 21: 167-178 (2002).
Klutke,
C.G., Raz, S., “Evaluation and Treatment of the Incontinent
Female Patient,” The Urologic Clinics N.A., vol. 22,
no. 3, August, 1995.
Raz
S., Little N.A., Saad J., “Female Urology,” Campbell’s
Urology, sixth ed., vol. 3, chapter 75, 7282-2828, (Walsh,
Retik, Stamey, Vaugham, editors).
Wein,
A.J., Levin, R.B., Barrett, D.M., “Voiding Function
and Dysfunction,” Adult and Pediatric Urology, second
ed., vol. 1, chapter 28 A&B, 933-1091.
Wein,
A.J., “Neuromuscular Dysfunction of the Lower Urinary
Tract,” Campbell’s Urology, sixth ed., vol. 1,
chapter 12, 573-658, (Walsh, Retik, Stamey, Vaugham, editors).
Blaivas,
J.G., “Intrinsic Sphincter Deficiency,” Campbell’s
Urology Update No. 17, 1-11, 1996, (Walsh, Retik, Stamey,
Vaughan, editors).
Resnick,
N.M., “An 89-Year-Old Woman With Urinary Incontinence,”
JAMA, vol. 276, 1832-1840, 1996.
“Clinical
Practice Guideline for Urinary Incontinence in Adults,”
Agency for Health Care Policy and Research, 1996.
“Let’s
Talk About Bladder Control for Women,” National Kidney
and Urologic Diseases Information Clearing House, National
Institute of Diabetes and Digestive Kidney Diseases, National
Institutes of Health.
Fryman, R.J., Abrams, P., “Current Diagnosis in the
Management of Men With Lower Urinary Tract Symptoms,”
Campbell’s Urology Update Vol. 1, no. 4., 2000 (Walsh,
Retik, Vaughan, Wein, editors).
Abams,
P., Klvemark, B., “Frequency Volume Charts: An Indispensable
Part of Lower Urinary Tract Assessment,” Scand J Urol
Nephrol (suppl 179) 30: 47-53, 1996.
Ditropan
XL, prescribing information, Alza Corporation, Palo Alto,
CA., 1999.
Detrol
LA, prescribing information, Pharmacia Corporation, Peapack,
NJ.
The
Aging Male
Tenover
J.L., “Testosterone and the aging male,” J Androl
1997 18(2):103-106.
Hajjar
R.R., Kaiser F.E., Morley J.E., “Outcomes of long-term
testosterone replacement in older hypogonadal males: A retrospective
analysis,” J Clin Endocrinol Metab 1997; 82: 3793-6.
Silber
S.J., “Effects of age on male fertility,” Semin
Reprod Endocrinol 1991; 9: 241-8.
Schwartz
D., Mayaux M.J., Spira A., Moscato M.L., Jouannet P., Czyglik
F., David G., “Semen characteristics as a function of
age in 833 fertile men,” Fertil Steril 1983; 39: 530-5.
Haidl
G., Jung A., Schill W.B., “Aging and sperm function,”
Hum. Reprod. 1996; 11: 558-60.
Bremner
W.J., Vitiello M.V., Prinz P.N., “Loss of circadian
rhythmicity in blood testosterone levels with aging in normal
men,” J Clin Endocrinol Metab 1983; 56: 1278-81.
Wermer
A.A., “The male climacteri,” JAMA 1939; 119: 1441-3.
Feldman
H.A., Goldstein I., Hatzichristou D.G., Kranc R.J., McKinlay
J.B., “Impotence and its medical and psychosocial correlates:
Results of the Massachusetts Male Aging Study,” J Urol
1994; 151: 54-61.
Muller
J.F., Mittleman A., Maclure M., Sherwood J.B., Tofler G.H.,
“Triggering myocardial infarction by sexual activity.
Low absolute risk and prevention by regular physical exertion.
Determinants of Myocardial Infarction Onset Study Investigators,”
JAMA 1996; 275: 1405-9.
Hajjar
R.R., Kaiser F.E., Morley J.E., “Outcomes of long-term
testosterone replacement in older hypogonadal males: A retrospective
analysis,” J Clin Endocrinol Metab 1997; 82: 3793-6.
Tremblay
R.R., Morales A., “Canadian practice recommendations
for screening, monitoring and treating men affected by andropause
or partial androgen deficiency,” The Aging Male 1998;
1: 213-8.
Anderson
R.A., Wallace E.M., Wu F.C.W., “Effect of testosterone
enanthate on serum lipoproteins in man,” Contraception
1995; 52: 115-9.
Crook
D., “Androgen therapy in the aging male: assessing the
effect on heart disease,” The Aging Male 1999; 2: 151-6.
|
